{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:47:25Z","timestamp":1760550445125,"version":"3.37.3"},"reference-count":35,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP15K09019"],"award-info":[{"award-number":["JP15K09019"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>It is unclear whether multiple nonstructural (<jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>) 5A resistance\u2010associated substitutions (<jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>s) correlate with the outcome of sofosbuvir (<jats:styled-content style=\"fixed-case\">SOF<\/jats:styled-content>) and ledipasvir (<jats:styled-content style=\"fixed-case\">LDV<\/jats:styled-content>) therapy. We investigated the effects of multiple <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>5A <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>s in <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>5A inhibitor\u2010na\u00efve patients with chronic hepatitis C virus genotype\u00a01b infection treated with <jats:styled-content style=\"fixed-case\">SOF<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">LDV<\/jats:styled-content>. In 313 patients treated with <jats:styled-content style=\"fixed-case\">SOF<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">LDV<\/jats:styled-content>, we assessed the effects of multiple <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>5A <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>s on the sustained virological response (<jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content>). <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>s at L28, R30, L31, Q54, P58, Q62, A92, and Y93 in the <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>5A region were examined by direct sequencing. The prevalence of <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>s was as follows: 2.6% at L28, 8.7% at R30, 6.1% at L31, 48.7% at Q54, 9.9% at P58, 9.9% at Q62, 5.1% at A92, 13.8% at Y93, and 19.2% at L31 or Y93. A total of 133 patients had no <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>s. <jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content> was achieved in 98.7% of the patients. <jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content> rates significantly differed between patients with and without the L31 or Y93 <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content> (93.0% [53\/57] vs 100% [250\/250], <jats:italic>P<\/jats:italic>\u00a0=\u00a0.0011). In addition, among patients with the L31 or Y93 <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>, 29.8%, 45.6% and 24.6% had one, two and three or more <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>5A <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>s, respectively. The <jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content> rate was significantly lower in patients with the L31 or Y93 <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content> with more than three <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>5A <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>s compared to those with fewer than three <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>5A <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>s (71.4% [10\/14] vs 100% [43\/43], <jats:italic>P<\/jats:italic>\u00a0=\u00a0.0025). Although the prevalence of multiple <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>5A <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>s at baseline was low in <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>5A inhibitor\u2010na\u00efve patients, the presence of multiple <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>5A <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>s was associated with the effectiveness of <jats:styled-content style=\"fixed-case\">SOF<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">LDV<\/jats:styled-content> therapy.<\/jats:p>","DOI":"10.1111\/jvh.12850","type":"journal-article","created":{"date-parts":[[2017,12,24]],"date-time":"2017-12-24T10:37:08Z","timestamp":1514111828000},"page":"535-542","source":"Crossref","is-referenced-by-count":14,"title":["The presence of multiple <scp>NS<\/scp>5A <scp>RAS<\/scp>s is associated with the outcome of sofosbuvir and ledipasvir therapy in <scp>NS<\/scp>5A inhibitor\u2010na\u00efve patients with chronic <scp>HCV<\/scp> genotype 1b infection in a real\u2010world cohort"],"prefix":"10.1111","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-6760","authenticated-orcid":false,"given":"R.","family":"Kozuka","sequence":"first","affiliation":[{"name":"Department of Hepatology Osaka City University Graduate School of Medicine  Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hai","sequence":"additional","affiliation":[{"name":"Department of Hepatology Osaka City University Graduate School of Medicine  Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Motoyama","sequence":"additional","affiliation":[{"name":"Department of Hepatology Osaka City University Graduate School of Medicine  Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hagihara","sequence":"additional","affiliation":[{"name":"Department of Hepatology Osaka City University Graduate School of Medicine  Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Hepatology Osaka City University Graduate School of Medicine  Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Uchida\u2010Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hepatology Osaka City University Graduate School of Medicine  Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Department of Hepatology Osaka City University Graduate School of Medicine  Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Enomoto","sequence":"additional","affiliation":[{"name":"Department of Hepatology Osaka City University Graduate School of Medicine  Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Hepatology Osaka City University Graduate School of Medicine  Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kawada","sequence":"additional","affiliation":[{"name":"Department of Hepatology Osaka City University Graduate School of Medicine  Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-4864","authenticated-orcid":false,"given":"A.","family":"Tamori","sequence":"additional","affiliation":[{"name":"Department of Hepatology Osaka City University Graduate School of Medicine  Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31678-6"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2009.01163.x"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23691"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807650"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.04.004"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12689"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-015-1120-x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27113"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402454"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402355"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316366"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)70099-X"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-016-1290-1"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.06.002"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12549"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165339"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-016-1225-x"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24767"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12898"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240201"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20506"},{"key":"e_1_2_9_23_1","unstructured":"AASLD and IDSA.Recommendations for Testing Managing and Treating Hepatitis C2017 http:\/\/www.hcvguidelines.org\/."},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep01065"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18050962"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02494-12"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.03.030"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.11.022"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.11.012"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.449"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12376"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02606-15"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-016-1303-0"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512610"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0354-1"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12850","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.12850","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvh.12850","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.12850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T20:48:06Z","timestamp":1694810886000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.12850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1111\/jvh.12850"],"URL":"https:\/\/doi.org\/10.1111\/jvh.12850","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"type":"print","value":"1352-0504"},{"type":"electronic","value":"1365-2893"}],"subject":[],"published":{"date-parts":[[2018,1,17]]}}}